Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 57.00 | |
25 mg | In stock | $ 94.00 | |
50 mg | In stock | $ 151.00 | |
100 mg | In stock | $ 253.00 | |
500 mg | In stock | $ 632.00 |
Description | SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role. |
Synonyms | (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid |
Molecular Weight | 281.33 |
Formula | C13H15NO4S |
CAS No. | 1695562-36-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (195.5 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SXC 2023 1695562-36-7 Others SXC2023 SXC-2023 2-acetamido-3-(4-methylbenzoylthio)propanoic acid (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid inhibitor inhibit